Gender dependent effect of DHCR24 polymorphism on the risk for Alzheimer's disease

Neuroscience Letters

Volumn 526, Issue 1, 2012, Pages 20-23

  Fehér, Ágnes ^a   Juhász, Anna ^a   Pákáski, Magdolna ^a   Kálmán, János ^a   Janka, Zoltán ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

24 Dehydrocholesterol reductase (DHCR24); Alzheimer's disease; Apolipoprotein E4 (APOE); Rs600491; Seladin 1 (selective AD indicator); Single nucleotide polymorphism (SNP)

Indexed keywords

24 DEHYDROCHOLESTEROL REDUCTASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; NERVE TISSUE PROTEINS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RISK; SEX FACTORS;

EID: 84865640702     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.010     Document Type: Article

References (17)

1. Björkhem, Meaney S. Brain cholesterol: long secret life behind a barrier. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:806-815.
2. Cecchi C., Rosati F., Pensalfini A., Formigli L., Nosi D., Liguri G., Dichiara F., Morello M., Danza G., Pieraccini G., Peri A., Serio M., Stefani M. Seladin-1/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol content. Journal of Cellular and Molecular Medicine 2008, 12:1990-2002.
3. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Inc., Hillsdale, NJ, pp. 216-226. 2nd ed.
4. Crameri A., Biondi E., Kuehnle K., Lütjohann D., Thelen K.M., Perga S., Dotti C.G., Nitsch R.M., Ledesma M.D., Mohajeri M.H. The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO Journal 2006, 25:432-443.
5. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry 2006, 63:168-174.
6. Greeve I., Hermans-Borgmeyer I., Brellinger C., Kasper D., Gomez-Isla T., Behl C., Levkau B., Nitsch R.M. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. Journal of Neuroscience 2000, 20:7345-7352.
7. Iivonen S., Hiltunen M., Alafuzoff I., Mannermaa A., Kerokoski P., Puoliväli J., Salminen A., Helisalmi S., Soininen H. Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease. Neuroscience 2002, 113:301-310.
8. Luciani P., Deledda C., Rosati F., Benvenuti S., Cellai I., Dichiara F., Morello M., Vannelli G.B., Danza G., Serio M., Peri A. Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology 2008, 149:4256-4266.
9. Lämsä R., Helisalmi S., Hiltunen M., Herukka S.K., Tapiola T., Pirttilä T., Vepsäläinen S., Soininen H. The association study between DHCR24 polymorphisms and Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144B:906-910.
10. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
11. Peri A., Serio M. Estrogen receptor-mediated neuroprotection: the role of the Alzheimer's disease-related gene seladin-1. Neuropsychiatric Disease and Treatment 2008, 4:817-824.
12. Peri A., Benvenuti S., Luciani P., Deledda C., Cellai I. Membrane cholesterol as a mediator of the neuroprotective effects of estrogens. Neuroscience 2011, 191:107-117.
13. Pfrieger F.W. Cholesterol homeostasis and function in neurons of the central nervous system. Cellular and Molecular Life Sciences 2003, 60:1158-1171.
14. Selkoe D.J. Alzheimer's disease: genes, proteins and therapy. Physiological Reviews 2001, 81:741-766.
15. Stefani M., Liguri G. Cholesterol in Alzheimer's disease: unresolved questions. Current Alzheimer Research 2009, 6:15-29.
16. Turgeon J.L., Carr M.C., Maki P.M., Mendelsohn M.E., Wise P. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocrine Reviews 2006, 27:576-605.
17. Waterham H.R., Koster J., Romeijn G.J., Hennekam R.C., Vreken P., Andersson H.C., FitzPatrick D.R., Kelley R.I., Wanders R.J. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. American Journal of Human Genetics 2001, 69:685-694.